House Bill 7839
116th Congress(2019-2020)
Continuing Access to In-Home IVIG Act
Introduced
Introduced in House on Jul 29, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
7839
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Doris Matsui
grade
California
Arizona
California
California
Hawaii
Illinois
Nebraska
North Carolina
North Carolina
Ohio
Oklahoma
Texas
Texas
Washington
No House votes have been held for this bill.
Summary
Continuing Access to In-Home IVIG Act
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
July 29, 2020
07/29/2020
Referred to the Subcommittee on Health.
07/29/2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/29/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:45:48 PM